Elba Medina
@elbaonelida
Followers
1K
Following
4K
Media
158
Statuses
1K
Nephrologist, @HGM_OD, @NSMCInternship #NSMC 2024 , @FacMedicinaUNAM.
Ciudad de México
Joined September 2013
Happy to see our review paper published in CJASN on treatment of distal renal tubular acidosis @Dan_Batlle , @CJASN .👇🏻.
The September Issue of CJASN is now available online! . Topics covered this month include:.-Improving anemia targets with therapy assistance software .-Text versus smartphone app to monitor blood pressure and steps in CKD.and more! Explore he issues featured this month at
9
28
131
RT @markinho_gc: Manejo de Hipertensión arterial en el paciente con DM2. @endocatracha @magraziagirone.@PepaSolerR @chemachir.@mendez_bail….
0
3
0
0
25
0
RT @ISNkidneycare: DAPA-Tolvaptan: First trial of SGLT2 inhibition in ADPKD with background tolvaptan therapy @KIReports made it to the #TO….
0
9
0
RT @KIReports: Assessing #Social Participation Among #KidneyTransplant Recipients Using #PROMIS Computer Adaptive Testing. #VisualAbstract….
0
1
0
RT @NephJC: With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why….
0
27
0
RT @NephJC: 🎨Check out the beautiful #visualabstract by #NephJC intern Michelle Fravel . ⏰Chat happening on July 8, 9 pm EST, on 🦋. https:….
0
14
0
RT @hardik4u24: 🩺 The Silent Enemy: Renal Artery Stenosis (#RAS) 🫘. ⚠️Starts silent—ends in 🧠RAAS chaos, 🫁flash edema, & 📉renal doom!. 🔬Cat….
0
32
0
RT @wisit661: 🚨 Hallucinations in Generative AI: A Critical Challenge for Nephrology — and How to Handle Them ⭐️ @ASNKidney AI community fo….
0
13
0
RT @MayoClinicNeph: Lower Podocyte Number per Glomerulus Associates With Progressive CKD. @AndrewRuleMD @KIReports .
0
12
0
RT @DanielDiazNF: Malignancies and glomerulonephritis:. ▫️Occult malignancies generally manifest within 1 year of initial GN diagnosis. ▫️T….
0
52
0
RT @NephJC: 🥇1st #NephJCshort is.@hswapnil 's take on @JAMA_current BedMed trial and chronotherapy in hypertension.
0
4
0
RT @NephJC: CAPTIVATE trial is a multicenter, phase 3, adaptive, platform, RCT #NephTrials #NephJC. 🎯 Aim: find the best treatment, or comb….
0
4
0
0
12
0
Class of 2025, #NephJC interns. The adventure start now ! 🤩.🔗
⭐️Find out more about #NephJC internship and new interns. @FravelShellie @sejalplakhani @sejvish79 @meyyappannephro @msocoMD @DrAkshayaJ @SridattaPawar @DrSaiVani1 @AgavriloaeiB @roxnonna23 @salinesalut @hswapnil .
0
0
11
RT @RafaelReyes_MD: Administrar bicarbonato en pacientes críticos con acidosis metabólica redujo la mortalidad a 30 días en 1.9% (RR 0.86,….
0
147
0